Other OTC - Delayed Quote USD

Comera Life Sciences Holdings, Inc. (CMRA)

0.0361 0.0000 (0.00%)
At close: April 26 at 12:31 PM EDT
Key Events
Loading Chart for CMRA
DELL
  • Previous Close 0.0361
  • Open 0.0361
  • Bid --
  • Ask --
  • Day's Range 0.0361 - 0.0361
  • 52 Week Range 0.0220 - 0.8260
  • Volume 267
  • Avg. Volume 21,328
  • Market Cap (intraday) 1.11M
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

comeralifesciences.com

12

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CMRA

Performance Overview: CMRA

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CMRA
34.36%
S&P 500
6.92%

1-Year Return

CMRA
95.30%
S&P 500
25.26%

3-Year Return

CMRA
99.64%
S&P 500
22.00%

5-Year Return

CMRA
--
S&P 500
38.03%

Compare To: CMRA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CMRA

Valuation Measures

Annual
As of 4/26/2024
  • Market Cap

    1.11M

  • Enterprise Value

    -486.64k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.71

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    -0.49

  • Enterprise Value/EBITDA

    0.05

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -119.35%

  • Return on Equity (ttm)

    -1,629.02%

  • Revenue (ttm)

    1M

  • Net Income Avi to Common (ttm)

    -9.35M

  • Diluted EPS (ttm)

    -0.2200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.77M

  • Total Debt/Equity (mrq)

    549.04%

  • Levered Free Cash Flow (ttm)

    -2.99M

Company Insights: CMRA

Fair Value

0.0361 Current
 

Dividend Score

0 Low
CMRA
Sector Avg.
100 High
 

Hiring Score

0 Low
CMRA
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
CMRA
Sector Avg.
100 High
 

Research Reports: CMRA

  • Daily – Vickers Top Insider Picks for 03/13/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 03/10/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 03/09/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     
  • Daily – Vickers Top Insider Picks for 03/08/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

     

People Also Watch